- Home
- RKTO vs DSX.WS Comparison
RKTO vs DSX.WS Comparison
Compare RKTO & DSX.WS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$0.35
N/A
Current Price
$0.14
Company Overview
Basic Information| Metric | RKTO | DSX.WS |
|---|---|---|
| Founded | 2017 | N/A |
| Country | United States | Greece |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.9M | 17.4M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | RKTO | DSX.WS |
|---|---|---|
| Price | $0.35 | $0.14 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 272.4K | 11.1K |
| Earning Date | 11-24-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.69 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.33 | $0.08 |
| 52 Week High | $1.19 | $0.17 |
Technical Indicators
Market Signals| Indicator | RKTO | DSX.WS |
|---|---|---|
| Relative Strength Index (RSI) | 21.62 | N/A |
| Support Level | N/A | N/A |
| Resistance Level | $0.77 | N/A |
| Average True Range (ATR) | 0.04 | 0.00 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 8.20 | 0.00 |
Price Performance
Historical Comparison RKTO
DSX.WS
About RKTO Rocket One Inc. Common Stock
Rocket One Inc is focused on developing and commercializing infrastructure for the orbital economy, including next-generation nanomagnetic AI chip technology designed for radiation-tolerant, energy-constrained environments such as low-Earth orbit, deep-space platforms, and defense systems. The company also intends to pursue opportunities related to nano-launch systems and nanosatellite deployment. In addition, its biotechnology operations, conducted through a wholly owned subsidiary, include development programs such as HT-001, HT-KIT, HT-ALZ, and a GDNF-based metabolic program.